摘要
自19世纪60年代末期第1例造血干细胞移植成功以来，造血干细胞移植为血液系统疾病、实体肿瘤、遗传和代谢性疾病提供了一种重要的治疗方式。但移植后感染性并发症很常见，尤其肺部感染具有较高的发病率和病死率。本文即对造血干细胞移植后肺部感染的诊治特点作一综述。
Since the first hematopoietic stem cell transplantation （HSCT） succeeded in 1960s, HSCT has offered a therapeutic option for high-risk malignant haematopoietic disorders,solid tumor,and genetic metabolic disease. However, infectious complication after transplantation is common, especially the morbidity and mortality of pulmonary infection are higher. This article reviews the characteristics of current diagnostic and therapeutic advancement of pulmonary infections after HSCT.
出处
《国际呼吸杂志》
2014年第2期131-135,共5页
International Journal of Respiration
关键词
造血干细胞移植
肺部感染
移植物抗宿主病
Hematopoietic stem cell transplantation
Pulmonary infections
Graft versus-host disease
